Quiver Bioscience

Quiver Bioscience is an AI-driven therapeutics company focused on accelerating the discovery of empirically grounded treatments for neurological diseases. They leverage a platform integrating scalable biology, advanced technology, and AI models to identify novel therapeutic targets and candidate molecules, aiming to deliver safer, more effective CNS drugs faster and at lower cost. Their approach utilizes patient-derived stem-cell models and all-optical electrophysiology to gain insights into complex brain biology and assess drug efficacy and toxicity.